Frank McCormack
Physician · UC Health
Credentials: · · · ·
History
Research
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis
New England Journal of Medicine · 2008 · 968 citations
Efficacy and safety of sirolimus in lymphangioleiomyomatosis
New England Journal of Medicine · 2011 · First of 27 authors · Corresponding · 858 citations
Pediatric Neurology · 2021 · 553 citations
38 papers · 2 as a fellow
29 papers
27 papers
- JM
19 papers
12 papers
10 papers
10 papers
9 papers
Grants
- 2026–2031
Clinical Trial Readiness for Rare Lung Diseases
National Heart, Lung, and Blood Institute · U54
Contact PI · $1.8M · University of Cincinnati
- 1994–2030
Pulmonary Development and Disease Pathogenesis Training Program
National Heart, Lung, and Blood Institute · T32
PI · $3.6M · Cincinnati Childrens Hosp Med Ctr
- 2023–2027
Novel Mechanisms of Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.5M · University of Cincinnati
- 2021–2026
Role of Pulmonary Osteoclast-Like Cells in Lung Injury
Department of Veterans Affairs · I01
Contact PI · Cincinnati Va Medical Center Research
Clinical trials
- 2016–2019
Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
Principal investigator · Terminated · Phase 2
Baylor College of Medicine
- 2014–2015
The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)
Principal investigator · Completed · Phase 1
Tony Eissa
- 2011–2014
Letrozole for Lymphangioleiomyomatosis
Principal investigator · Completed · Phase 2
University of Cincinnati
- 2018–2025
Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial
Study chair · Active not recruiting · Phase 3
University of Cincinnati